Shankar Ramaswamy, M.D.
FounderFounder at Kriya Therapeutics
Raleigh-Durham-Chapel Hill Area
FoundedKriya Therapeutics
About
Shankar Ramaswamy, M.D., is Co-Founder, Chairman, and Chief Executive Officer of Kriya Therapeutics, a biopharmaceutical company developing and manufacturing one-time gene therapies for prevalent chronic diseases. He was previously part of the early team at Roivant Sciences, where he worked on pipeline evaluation and the launch of Axovant Sciences, leading corporate development and contributing to the company's 2015 initial public offering, which raised over $360 million. Ramaswamy holds a Medical Degree from Brown University and an undergraduate degree in Economics from Harvard University.
Founder at Kriya Therapeutics
Intro paths
→
In turn, Shankar can intro founders to Kriya Therapeutics's investors below.
Kriya Therapeutics's investors · 9
Alumni VenturesManchester · $100K – $10M checks · since 2025AmploHouston · since 2025Amplo VenturesSpring · since 2021Bluebird VenturesPalo Alto · since 2021Foresite CapitalWest Hollywood · since 2021JDRF T1D FundBoston · since 2021Narya CapitalColumbus · since 2021Patient Square CapitalMenlo Park · since 2021Premji InvestMenlo Park · since 2021
Co-founders at Kriya Therapeutics
SR
Shankar RamaswamyCo-Founder, Chairman & CEO
RJ
Roger JeffsCo-Founder & Vice Chairman
FW
Fraser WrightScientific Co-Founder & Chief Gene Therapy Officer
Experience
- Kriya TherapeuticsCo-Founder and Chief Executive Officercurrent2019 — presentRaleigh-Durham-Chapel Hill Area
- Axovant SciencesChief Business Officer2019New York, New York
- Axovant SciencesSenior Vice President, Business Development and Operations2018New York, New York
- Axovant SciencesVice President, Global Medical Affairs2017 — 2018New York City Metropolitan Area
- Axovant SciencesVice President, Medical and Scientific Communications2016 — 2017New York City Metropolitan Area
- Axovant SciencesSenior Scientist, Lewy Body Dementia Programs2016New York City Metropolitan Area
- Axovant SciencesVice President Corporate Development2015 — 2016New York City Metropolitan Area
- Roivant SciencesAnalyst2014 — 2015New York City Metropolitan Area
Skills & more
Strategy3Strategic PlanningEntrepreneurship1Start-ups2Strategic PartnershipsVenture CapitalFinancial ModelingBusiness DevelopmentSocial MediaCompetitive Analysis
From Shankar's professional profile.
Frequently asked questions
- Who is Shankar Ramaswamy, M.D.?
- Shankar Ramaswamy, M.D., is Co-Founder, Chairman, and Chief Executive Officer of Kriya Therapeutics, a biopharmaceutical company developing and manufacturing one-time gene therapies for prevalent chronic diseases. He was previously part of the early team at Roivant Sciences, where he worked on pipeline evaluation and the launch of Axovant Sciences, leading corporate development and contributing to the company's 2015 initial public offering, which raised over $360 million. Ramaswamy holds a Medical Degree from Brown University and an undergraduate degree in Economics from Harvard University.
- Where does Shankar Ramaswamy, M.D. work?
- Shankar Ramaswamy, M.D. is Founder of Kriya Therapeutics.
- What companies did Shankar Ramaswamy, M.D. found?
- Shankar Ramaswamy, M.D. founded Kriya Therapeutics.
- Where did Shankar Ramaswamy, M.D. go to school?
- Shankar Ramaswamy, M.D. studied at Harvard University (Bachelor of Arts (A.B.), Economics); Brown University (Doctor of Medicine (M.D.)).
Same school
Also attended Harvard University1,558
Alfred LinPartner at Sequoia CapitalChris DixonFounder & Managing Partner of a16z crypto at Andreessen HorowitzSarah TavelVenture Partner at BenchmarkDanny RimerPartner at Index VenturesLaela SturdyManaging Partner at CapitalGBill GatesCo-founder of Microsoft; Chair of the Gates Foundation
+ 1,552 more
Also attended Brown University423
Theresia GouwFounding Partner at Acrew CapitalJoe GebbiaCo-founder of AirbnbDylan FieldCo-founder, CEO & Chair of FigmaAlexis AbramsPartner, General Counsel at Felicis VenturesJohn KimInvestor Relations at General CatalystAli Fisher SweetInvestor at Index Ventures
.png)
+ 417 more
